Myasthenia gravis: open trials in South Korea

• NCT04951622

  A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  Trial Treatment · Phase 3 · Janssen Research & Development, LLC

  Pusan National University Hospital, Busan · Kyungpook National University Chilgok Hospital, Daegu · Kyungpook National University Hospital, Daegu · Severance Hospital, Yonsei University Health System, Seoul

  Registry updated 2026-11-05

• NCT06055959

  A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

  Trial Treatment · Phase 2/3 · UCB Biopharma SRL

  Mg0014 20104, Seoul · Mg0014 20220, Seoul

  Registry updated 2026-11-05

• NCT06463587

  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  Trial Treatment · Phase 3 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

  Kyungpook National University Chilgok Hospital, Daegu · Chonnam National University Hospital, Gwangju · Korea University Anam Hospital, Seoul · Severance Hospital, Yonsei University Health System - Division of Infectious Diseases, Seoul · Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul · Samsung Medical Center, Seoul · Asan Medical Center, Seoul · Keimyung University Dongsan Hospital, Seoul

  Registry updated 2026-10-21

• NCT06435312

  An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

  Trial Treatment · Phase 3 · UCB Biopharma SRL

  Mg0015 20220, Seoul

  Registry updated 2026-10-02

• NCT06312644

  Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

  Research · Alexion Pharmaceuticals, Inc.

  Seoul

  Registry updated 2026-04-16

All Myasthenia gravis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error